A new trading day began on Monday, with AnaptysBio Inc (NASDAQ: ANAB) stock price up 8.22% from the previous day of trading, before settling in for the closing price of $22.27. ANAB’s price has ranged from $13.36 to $41.31 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 172.96% over the past five years. Meanwhile, its annual earnings per share averaged 1.24%. With a float of $25.98 million, this company’s outstanding shares have now reached $26.60 million.
Let’s look at the performance matrix of the company that is accounted for 117 employees. In terms of profitability, gross margin is 95.8%, operating margin of -257.84%, and the pretax margin is -289.74%.
AnaptysBio Inc (ANAB) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of AnaptysBio Inc is 14.63%, while institutional ownership is 98.16%. The most recent insider transaction that took place on Sep 23 ’24, was worth 58,005. In this transaction Chief Medical Officer of this company sold 1,500 shares at a rate of $38.67, taking the stock ownership to the 15,398 shares. Before that another transaction happened on Sep 23 ’24, when Company’s Officer proposed sale 1,500 for $38.67, making the entire transaction worth $58,005.
AnaptysBio Inc (ANAB) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -1.59 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.74 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1.24% per share during the next fiscal year.
AnaptysBio Inc (NASDAQ: ANAB) Trading Performance Indicators
Here are AnaptysBio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 10.23. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.07, a number that is poised to hit -1.55 in the next quarter and is forecasted to reach -6.40 in one year’s time.
Technical Analysis of AnaptysBio Inc (ANAB)
AnaptysBio Inc (NASDAQ: ANAB) saw its 5-day average volume 0.44 million, a positive change from its year-to-date volume of 0.35 million. As of the previous 9 days, the stock’s Stochastic %D was 79.49%. Additionally, its Average True Range was 1.84.
During the past 100 days, AnaptysBio Inc’s (ANAB) raw stochastic average was set at 26.08%, which indicates a significant decrease from 85.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 78.43% in the past 14 days, which was lower than the 81.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $29.12, while its 200-day Moving Average is $27.77. Nevertheless, the first resistance level for the watch stands at $25.36 in the near term. At $26.63, the stock is likely to face the second major resistance level. The third major resistance level sits at $28.15. If the price goes on to break the first support level at $22.58, it is likely to go to the next support level at $21.06. Assuming the price breaks the second support level, the third support level stands at $19.80.
AnaptysBio Inc (NASDAQ: ANAB) Key Stats
With a market capitalization of 771.44 million, the company has a total of 30,429K Shares Outstanding. Currently, annual sales are 17,160 K while annual income is -163,620 K. The company’s previous quarter sales were 30,020 K while its latest quarter income was -32,850 K.
